SCHEMBL9879414

SCHEMBL9879414

C=CCOC(=O)CCCC(c1ccccc1)[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 2/20 0.40
CYP3A4 P08684 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
CASP1 P29466 4/20 0.36
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
GSR P00390 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.33
HDAC2 Q92769 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9879546 0.81 SMN1; SMN2 (0.52) PKMSMN1; SMN2TSHRCYP3A4NPSR1
SCHEMBL9879144 0.79 PKM (0.50) PKMSMN1; SMN2TSHRCYP3A4NPSR1
SCHEMBL4726274 0.78 TBXAS1 (0.42) SMN1; SMN2TSHRCYP2C19ALDH1A1GSR
SCHEMBL17999452 0.75 CYP3A4 (0.44) SMN1; SMN2CYP3A4NPSR1CYP2C19ALDH1A1
SCHEMBL3269693 0.75 CYP3A4 (0.34) SMN1; SMN2TSHRCYP3A4NPSR1CASP1
SCHEMBL475204 0.72 ALDH1A1 (0.43) TSHRCYP3A4CYP2C19ALDH1A1HSD17B10
SCHEMBL15617420 0.72 GSR (0.36) GSRCYP2D6
SCHEMBL3024154 0.72 CA12 (0.44) TSHRCYP3A4ALDH1A1GSR
SCHEMBL725647 0.71 CYP3A4 (0.43) PKMSMN1; SMN2TSHRCYP3A4NPSR1
SCHEMBL11091345 0.71 SMN1; SMN2 (0.56) PKMSMN1; SMN2TSHRCYP3A4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5008285-A Antiarthritic agent with low gastric irritability side effect HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-16 US disclosed
EP-0159684-B1 (6,11-DIHYDRO-11-OXODIBENZ(B,E)OXEPINYL)PENTANOIC ACIDS AND DERIVATIVES, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-09-27 EP disclosed
EP-0159684-A2 (6,11-Dihydro-11-oxodibenz(b,e)oxepinyl)pentanoic acids and derivatives, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-10-30 EP disclosed